Reducing of LXRβ and PPARγ mRNA in M-CSF stimulated macrophages in patients with levels atherosclerosis
- Authors: Demina Y.P.1, Miroshnikova V.V.1, Mayorov N.V.2, Davydenko V.V.2, Schwarzman A.L.1
-
Affiliations:
- B. P. Konstantinov Nuclear Physics Institute in Saint-Petersburg
- Pavlov First Saint-Petersburg State Medical University
- Issue: Vol 12, No 1 (2014)
- Pages: 14-18
- Section: Articles
- URL: https://journals.rcsi.science/ecolgenet/article/view/2470
- DOI: https://doi.org/10.17816/ecogen12114-18
- ID: 2470
Cite item
Full Text
Abstract
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
Yekaterina Petrovna Demina
B. P. Konstantinov Nuclear Physics Institute in Saint-Petersburg
Email: citritt@gmail.com
Molecular and Radiation Biophysics Department
Valentina Vadimovna Miroshnikova
B. P. Konstantinov Nuclear Physics Institute in Saint-Petersburg
Email: mutantropol@mail.ru
Molecular and Radiation Biophysics Department
Nikolay Vladimirovich Mayorov
Pavlov First Saint-Petersburg State Medical University
Email: nikolaj-majorov@yandex.ru
Hospital Surgery Department N 2
Vladimir Valentinovich Davydenko
Pavlov First Saint-Petersburg State Medical University
Email: kuzet@mail.ru
Hospital Surgery Department N 2
Alexander L`vovich Schwarzman
B. P. Konstantinov Nuclear Physics Institute in Saint-Petersburg
Email: aschwart1@yandex.ru
Molecular and Radiation Biophysics Department
References
- Amoruso A., Bardelli C., Fresu L. G. et al. (2009) Peroxisome Proliferator-Activated Receptor-Expression in Monocyte/Macrophages from Coronary Artery Disease Patients and Possible Gender Differences. J. Pharmacol. Exp Ther. V. 331 (2): P. 531-538.
- Apostoli A. J., Nicol C. J. (2012) PPAR Medicines and Human Disease: The ABCs of It All. PPAR Res. 2012:504918.
- Bensinger S. J., Tontonoz P. (2008) Integration of metabolism and inflammation by lipid-activated nuclear receptors. Nature. V. 454: P. 470-477.
- Calkin A. C., Tontonoz P. (2012) Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR. Nat. Rev. Mol. Cell Biol. V. 13 (4): P. 213-24.
- Giaginis C., Klonaris C., Katsargyris A. et al. (2011) Correlation of Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) and Retinoid X Receptor-alpha (RXR-alpha) expression with clinical risk factors in patients with advanced carotid atherosclerosis. Med. Sci. Monit. V. 17 (7): P. 381-391.
- Li A. C., Binder C. J., Gutierrez A. et al. (2004) Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma. J Clin. Invest. V. 114 (11): P. 1564-1576.
- Meurs I., Van Eck M., Van Berkel T. J. (2010) High-density lipoprotein: key molecule in cholesterol efflux and the prevention of atherosclerosis. Curr. Pharm. Des. V. 16: P. 1445-1467.
- Oosterveer M. H., Grefhorst A., Groen A. K. et al. (2010) The liver X receptor: control of cellular lipid homeostasis and beyond: implications for drug design. Prog. Lipid. Res. V. 49: P. 343-352.
- Rader D. J., Pure E. (2005) Lipoproteins, macrophage function, and atherosclerosis: beyond the foam cell? Cell metabolism. V. 1: P. 223-230.
- Soumian S., Gibbs R., Davies A. et al. (2005) mRNA expression of genes involved in lipid efflux and matrix degradation in occlusive and ectatic atherosclerotic disease. J. Clin. Pathol. V. 58: P. 1255-1260.
- Sueyoshi S., Mitsumata M., Kusumi Y. et al. (2010) Increased expression of peroxisome proliferator-activated receptor (PPAR)-alpha and PPAR-gamma in human atherosclerosis. Pathol. Res. Pract. V. 206 (7): P. 429-438.
- Wahli W., Michalik L. (2012) PPARs at the crossroads of lipid signaling and inflammation. Trends Endocrinol. Metab. V. 23 (7): P. 351-363.
- Zar J. H. (1998) Biostatistical Analysis. 4th edition. Prentice Hall.
![](/img/style/loading.gif)